Xlife Sciences AG Asset Resilience Ratio

Latest as of December 2025: 0.13%

Xlife Sciences AG asset resilience ratio. Xlife Sciences AG (XLS) has an Asset Resilience Ratio of 0.13% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Xlife Sciences AG (XLS) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CHF646.47K

≈ $817.31K USD Cash + Short-term Investments

Total Assets

CHF517.12 Million

≈ $653.78 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Xlife Sciences AG (2019–2025)

Asset resilience ratio of Xlife Sciences AG from 2019 to 2025. This chart shows how Xlife Sciences AG's Asset Resilience Ratio has changed over time. Read Xlife Sciences AG total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Xlife Sciences AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see XLS total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CHF0.00	0%
Short-term Investments	CHF646.47K	0.13%
Total Liquid Assets	CHF646.47K	0.13%

Asset Resilience Insights

Limited Liquidity: Xlife Sciences AG maintains only 0.13% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Xlife Sciences AG Industry Peers by Asset Resilience Ratio

Compare Xlife Sciences AG's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	35.16%
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	Biotechnology	23.15%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Achieve Life Sciences Inc F:SP4P	Biotechnology	3.60%

Xlife Sciences AG Asset Resilience Ratio by Year (2019–2025)

Xlife Sciences AG asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for Xlife Sciences AG.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.13%	CHF646.47K ≈ $817.31K	CHF517.12 Million ≈ $653.78 Million	+0.11pp
2024-12-31	0.02%	CHF99.03K ≈ $125.20K	CHF540.37 Million ≈ $683.18 Million	-0.02pp
2023-12-31	0.04%	CHF218.71K ≈ $276.51K	CHF511.99 Million ≈ $647.30 Million	0.00pp
2022-12-31	0.05%	CHF221.04K ≈ $279.45K	CHF490.23 Million ≈ $619.78 Million	-0.36pp
2021-12-31	0.41%	CHF1.96 Million ≈ $2.47 Million	CHF480.06 Million ≈ $606.93 Million	-2.13pp
2020-12-31	2.53%	CHF4.70 Million ≈ $5.95 Million	CHF185.68 Million ≈ $234.75 Million	+0.88pp
2019-12-31	1.65%	CHF2.54 Million ≈ $3.21 Million	CHF154.02 Million ≈ $194.72 Million	--

pp = percentage points

About Xlife Sciences AG

SW:XLS Switzerland Biotechnology

Market Cap

$65.63 Million

CHF51.91 Million CHF

Market Cap Rank

#20667 Global

#197 in Switzerland

Share Price

CHF9.00

Change (1 day)

+2.27%

52-Week Range

CHF8.50 - CHF26.00

All Time High

CHF52.00